Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.

Annals of surgical oncology - 1 Dec 2015

Margonis Georgios A, Spolverato Gaya, Kim Yuhree, Karagkounis Georgios, Choti Michael A, Pawlik Timothy M

Abstract excerpt

PURPOSE: To investigate the prognostic value of KRAS in a large cohort of patients undergoing liver resection for colorectal liver metastases (CRLM). METHODS: Between 2003 and 2013, 334 patients underwent hepatic resection for CRLM at Johns Hopkins Hospital and met the inclusion criteria. Clinicopathologic characteristics, perioperative details, and outcomes were stratified by KRAS status-mutant KRAS (mtKRAS)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatectomy

Share to Liver Neoplasms

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins p21(ras)

Share to Survival Rate

Source

Identifiers

PMID: 26077912
DOI: 10.1245/s10434-015-4587-z

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.PMID 26077912Read ↗

KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.Semantic proximity Read ↗

From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.Semantic proximity Read ↗

Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.Semantic proximity Read ↗

KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.Semantic proximity Read ↗

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis.Semantic proximity Read ↗

Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.Semantic proximity Read ↗

The effects of resection margin and KRAS status on outcomes after resection of colorectal liver metastases.Semantic proximity Read ↗

Clinical impact of KRAS mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastasesSemantic proximity Read ↗

Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases.Semantic proximity Read ↗

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.Semantic proximity Read ↗

Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.Semantic proximity Read ↗

RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.